Recommendation for adults and adolescents based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to ...

Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinionRecommendation for adults and ...

In a recent column, you wrote about reducing cholesterol with the help of statins along with a PCSK9i, such as Repatha or ...

In a recent column, you wrote about reducing cholesterol with the help of statins along with a PCSK9i, such as Repatha or Praluent. My question is: Are these PCSK9is at all beneficial if one cannot ...

Bank of America Global Healthcare Conference 2025 September 23, 2025 4:50 AM EDTCompany ParticipantsPaul Hudson - CEO ...

ANSWER: Most people recover their loss of smell after COVID. Having had this for two years is a bad sign; however, the fact that she does have some sense of smell is a good sign.

Get going with our next company presenter at the BofA Healthcare Conference here in London. Pleased to be introducing Teva Pharmaceuticals and CEO, Richard Francis. My name is Jason Gerberry. I'm one ...

Ozempic (semaglutide) is injected once weekly under the skin of your abdomen, upper arm, or thigh. Your doctor will show you how to do this before your first dose. To prevent skin issues, rotate your ...

Did you ever scroll through your social media timeline and get that nagging sense of needing to look a particular way? That’s what’s going on with the newest beauty trend dermal fillers among Gen Z ...

TIME and Statista have named 500 companies doing best for the Earth Methodology: How TIME and Statista Determined the World's Most Sustainable Companies of 2025 In the fight against climate change, ...

An announcement from Sanofi ( ($SNY) ) is now available. On September 22, 2025, Sanofi and Regeneron announced that their drug Dupixent received a ...

French drugmaker Sanofi SA (NASDAQ:SNY) stock fell sharply Thursday after late-stage trial results for amlitelimab, its potential successor to blockbuster eczema drug Dupixent, failed to match ...